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ABSTRACT
PURPOSE: The present study aimed at studying the effects of vasoactive intestinal peptide (VIP) 
microinjected unilaterally into the hippocampal CA1 area on the locomotor activity of rats with olfactory 
bulbectomy. Hippocampus has been chosen as it is a region with high VIP receptor density as well as a brain 
structure implicated in many types of disorders, including depression. 
MATERIAL AND METHODS: Olfactory bulbectomy (OBX) rat is among the well-validated animal models 
of depression. The changes in locomotor activity of OBX rats were registered in an Opto Varimex apparatus. 
RESULTS: VIP injected into the left CA1 area at doses of 10 ng and 100 ng aggravated OBX rat hyperactivi-
ty by increasing the locomotor activity. VIP (in a dose of 100 ng) microinjected into the right CA1 area pro-
duced an opposite effect by decreasing the number of both horizontal and vertical movements in OBX rats 
as compared to saline-treated OBX controls. 
CONCLUSION: Our data reveal a pronounced lateralized VIP effect on the locomotor activity of OBX rats 
and point to a possible VIP involvement in the mechanisms of the olfactory bulbectomy syndrome in rats.
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INTRODUCTION
Vasoactive intestinal peptide (VIP) is a neuro-
peptide which is widely distributed in the central and 
peripheral nervous systems (24). Studies have pro-
vided data that VIP can act as a neurotransmitter, 
neuromodulator, neurotrophic and neuroprotective 
factor thus affecting the neural activity and the 
functioning of different nervous circuits (10,23). VIP 
has been highlighted as a key signaling pathway in 
the suprachiasmatic nuclei of the hypothalamus, 
which are considered as the master clock controlling 
daily rhythms in mammals (1). 
VIP and its receptors are expressed in many 
brain regions including cortex, hippocampus, 
amygdala and hypothalamus (17). VIP has been im-
plicated in a variety of biological activities including 
hormonal regulation, immunomodulation, regula-
tion of feeding behaviour and modulation of learned 
behaviours. It has been suggested to participate in 
the pathophysiology of neurological and psychiatric 
disorders such as Alzheimer’s disease and depression. 
The publications about VIP lowered levels in the 
cerebrospinal fluid of patients with depression 
suggest its possible role in the neurobiological 
mechanisms of affective disorders (9,20). 
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The olfactory bulbectomy (OBX) is an animal 
model of depression that produces a constella-
tion of behavioural, physiological, neurochemical 
and neuroendocrine changes of great relevance to 
clinical depression. The bilateral removal of olfacto-
ry bulbs causes a major dysfunction of the cortical-
hippocampal-amygdala circuit that underlies the 
behavioural changes (15,26). OBX rats typically 
exhibit hyperactivity in an open field test. 
There are data about VIP involvement in the 
locomotor activity of rodents, however, its role in 
the hyperactivity exhibited by OBX rats has not been 
examined yet. We have previously demonstrated a 
modulatory effect of VIP (in a dose of 10 ng) micro-
injected bilaterally into hippocampal CA1 area on 
the exploratory behaviour of OBX rats (14). 
The objective of the present study was to ivesti-
gate the effects of VIP microinjected unilaterally into 
CA1 area on the locomotor activity of OBX rats. 
MATERIAL AND METHODS
Experimental model of depression in OBX 
Bilateral OBX was performed according to 
the method described by Kelly et al. (15). Male Wi-
star rats were anaesthetized with Calypsol (in a 
dose of 50 mg/kg i.p.) and placed in a stereotaxic 
apparatus (Stoelting Co., USA). Surgical procedure 
involved drilling two burr holes 2 mm in diameter 
at the points 8 mm anterior to bregma and 2 mm 
from the midline on it’s both sides as coordinates 
were estimated according to the stereotaxic atlas 
of Pellegrino and Cushman (19). The bulbs were 
aspirated with a stainless needle attached to a water 
pump. After the surgery, the rats were housed in 
groups of two and were handled and weighed daily 
during a 15-day period. 
Stereotaxic implantation and drug injection 
into hippocampal CA1 area of OBX rats
After the anaesthesia, OBX rats were placed in 
the stereotaxic apparatus and guide cannulae (right 
and left) were implanted into CA1 hippocampal area 
according to the coordinates of the stereotaxic atlas 
(10). After surgery, the animals were allowed 7 days 
to recover prior to the behavioural tests. During the 
recovery period they were handled daily. 
The rats were microinjected into left or right 
hippocampal CA1 areas with VIP (in a dose of 10 
ng and 100 ng) or with saline (1 μL). VIP (Sigma) 
was dissolved ex tempore in saline and 1 μL of VIP 
solution (pH 7,4) was infused 5 min before the test 
for locomotor activity. Immediately prior to sacrifice, 
the rats were injected with 1 μL of 2% fast green dye 
through the injection cannula. Brains were removed, 
and bulbectomy was verified macroscopically. 
Injection sites were verified anatomically in 25 mm 
coronal brain sections cut through the hippocampus. 
Test for locomotor activity
Locomotor activity was recorded in an Opto 
Varimex apparatus (Columbus Instruments, USA). 
The apparatus recorded the number of photo beam 
interruptions during animal movements in the 
experimental chamber. It provided selective counting 
of the number of horizontal and vertical movements 
in arbitrary units (AU). The rats were placed in the 
central quadrant of the activity monitor 5 min after 
VIP microinjection. The information was recorded 
automatically for a 30-min period of observation.
Statistical analysis
Data were processed by analysis of variance 
(ANOVA). Two-way ANOVA was used to process 
the data obtained for the total number of movements 
of VIP-treated OBX rats for a 30-min period. Where 
appropriate, ANOVA data were further analyzed by 
the t-test for post hoc group comparisons.
RESULTS
Repeated two-way ANOVA analysis on the 
effect of unilateral VIP microinjection on the 
number of horizontal movements in OBX rats for a 
30-min period of observation showed a significant 
effect of the factor ‘side’ (F
1,47
=87,058; p 0,001) and 
a significant interaction between the factors ‘drug’ x 
‘side’ (F
2,47
=40,667; p 0,001). 
VIP administered into the left CA1 area of 
OBX rats increased the total number of horizontal 
movements in both doses: for VIP (10 ng) (t=2,80; 
p 0,05) and for VIP (100 ng) (t=3,56; p 0,1), respective-
ly, while VIP microinjection (of 100 ng) into the right 
CA1 area significantly decreased the total number of 
horizontal movements (t=2,95; p 0,05) as compared 
to the saline-treated OBX controls (Fig. 1). VIP 
injected into the left CA1 area produced a greater 
total number of horizontal movements in both dos-
es: for VIP (10 ng) (t=7,89; p 0,001) and for VIP (100 
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ng) (t=10,74; p 0,001) as compared to the right-side 
microinjections (Fig. 1). 
Two-way ANOVA analysis of VIP effect (in 
a dose of 10 and 100 ng) on the number of vertical 
movements of OBX rats demonstrated a significant 
effect of the factor ‘drug’ (F
2,47
=12,161; p 0,001), the 
factor ‘side’ (F
1,47 
=159,614; p 0,001) and an interac-




The number of vertical movements was signif-
ically increased following VIP injection into the left 
CA1 area: for VIP (10 ng) (t=8,80; p 0,001) and for 
VIP (100 ng) (t=6,14; p 0,001), respectively, while VIP 
injection at a dose of 100 ng significantly decreased 
the number of vertical movements (t=3,61; p 0,01) as 
compared to the saline-treated OBX rats. Both dos-
es of VIP increased the number of vertical move-
ments in OBX rats following microinjection into the 
left CA1 area as compared to the right CA1: for VIP 
(10 ng) (t=8,70; p 0,001) and for VIP (of 100 ng) (t=7,70; 
p 0,001) (Fig. 2).
DISCUSSION
The present study showed a pronounced lat-
eralized effect of VIP on the locomotor activity 
of rats with a model of depression. Unilateral VIP 
microinjection (in a dose of 10 ng and 100 ng) into 
the left hippocampal CA1 area enhanced OBX rat lo-
comotor activity expressed as an increased number 
of both horizontal and vertical movements, while fol-
lowing injection into the right CA1 area, the higher 
VIP dose (100 ng) exerted an opposite, inhibitory ef-
fect exoressed as a decreased number of movements 
when compared to the saline-treated OBX controls. 
The hyperactivity in an open field is a typical 
behavioural phenomenon in OBX rats. It is considered 
an index of depressive-like behaviour in this animal 
model (15). In this respect, VIP locomotor stimulato-
ry effect after administration into the left CA1 area 
could be considered a sign of aggravated depression-
like state. 
Although behavioural VIP effects have been in-
vestigated, its involvement in the mechanisms of the 
depressive disorders has not been studied yet. Re-
cent data about the behavioural responses to VIP af-
ter administration in the brain show different, some-
times opposite effects, which may be also dependent 
on the initial state of the experimental animal. Stim-
ulatory VIP effects on rodent locomotor activity af-
ter i. c. v. administration were reported (12,16) while 
VIP injecton after brain injury (lobectomy) showed 
a regulatory influence and restored the impaired 
locomotion (21). An i.c.v. VIP injection reduced 
food intake and increased both activity and energy 
expenditure in rats. Thus its endogenous role in the 
hypothalamic control of energy homeostasis was 
suggested (8).
A correlation between locomotion and 
hippocampal VIP was reported, where rat locomo-
tor activity was associated with an increased VIP 
Fig. 1. VIP effects (10 ng and 100 ng) after unilater-
al injection into the hippocampal CA1 area of OBX rats 
on the total number of horizontal movements for a 30-
min period of observation. AU - arbitrary units, *p≤0,05; 
**p≤0,01 - comparison to the respective saline-injected 
OBX controls; 000p≤0,001 - comparison between right-side 
and left-side treated animals. n=8. Means (±S.E.M.) are 
presented
Fig. 2. VIP effects (100 ng) after unilateral injection 
into the hippocampal CA1 area of OBX rats on the total 
number of verical movements for a 30-min period of 
observation. AU - arbitrary units, **p≤0,01; ***p≤0,001 - 
comparison to the respective saline-injected OBX controls. 
000p≤0,001 - comparison between right-side and left-side 
treated animals. n=8. Means (±S.E.M.) are presented
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expression in hippocampal rat neurons along with 
an increased VIP mRNA in the hippocampus and 
motor cortex (7).
We have previously demonstrated a lateral-
ized VIP effect on the exploratory activity of rats 
(number of movements in a 5-min period of obser-
vation) after administration into hippocampal CA1 
area. VIP injection (50 ng and 100 ng) into the right 
CA1 area stimulated the activity, while that of 100 
ng into the left CA1 decreased the number of move-
ments (13). Interestingly, in the present study, the lo-
comotor stimulatory effect was exhibited after VIP 
injection into the left CA1 area in OBX rats. It is dif-
ficult to explain both mechanisms and the change 
of the lateralized locomotor effect in the OBX rats. 
It could be speculated that VIP modulatory effects 
on the neuronal excitability and on the release of 
neurotransmitters in the hippocampus (3,4,18) might 
be involved in the behavioural effect observed in the 
present investigation.
Left-right brain asymmetry (laterality), once 
believed to be a human characteristics, has now 
been found to be widespread among vertebrates 
(11). There is a lot of data concerning the functional, 
anatomical and neurochemical asymmetries in the 
brain of non-human primates and other animals 
including rats (5,6,22). There is evidence that rat 
asymmetric behavioural responses are, probably, due 
to asymmetry in some pathways or neurotransmitter 
systems. Recently, a morphological left-right 
asymmetry at the synaptic level in the hippocampus 
has been reported (25). 
Changes in the expression of neuropeptides in 
some brain areas have been established following 
bulbectomy (26). It could be hypothesized that an al-
tered hemispheric asymmetry in the number of VIP 
interneurons, the density of VIP receptors in the 
hippocampus, or asymmetry in the neurotransmitter 
systems with which VIP interacts might account for 
the lateralized behavioural responses of OBX rats. 
The neurodegenerative changes in the hippocampus 
after bulbectomy (26) and the compensatory 
reorganization of neuronal circuits could contribute 
to the lateralized VIP effects on locomotion of OBX 
rats, too. In this respect, our results are in accordance 
with the interhemispheric differences in OBX rats re-
ported elsewhere (2).
CONCLUSION 
The present study reveals a pronounced 
lateralized VIP effect following unilateral 
microinjection into the hippocampal CA1 area of 
rats with OBX  model of depression. The asymmetry 
in the behavioural responses to VIP suggests a 
possible involvement of VIP in the mechanisms of 
the olfactory bulbectomy syndrome in rats.
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